Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ZBIO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ZBIO
Zenas BioPharma, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ZBIO
Zenas BioPharma, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
ZBIO
with
LLY
Uncorrelated: r 0.19 · 499D.
No shared co-movers.
ZBIO, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
ZBIO
Zenas BioPharma, Inc.
Change
26.08
▼
−8.37%
· post 26.48
· delayed
Mkt cap
$1.8B
Revenue
$10M
Q3 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,361.39
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 5 '26
delayed
ZBIO
Zenas BioPharma, Inc.
vs
LLY
ELI Lilly & Co
26.08
▼
−8.37%
post 26.48
delayed
Price
1,371.32
▼
−3.29%
post 1,361.39
delayed
$1.8B
Mkt cap
$1.3T
Q3 FY26
$10M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
ZBIO
26.08
▼
−8.37%
vs
LLY
1,371.32
▼
−3.29%
After hours
Nov 5 '26
delayed